$PFE 0.49 Noisy
- Date
- Sep 30, 2026
- Mentions
- 1
- Unique authors
- 1
- Sector
- other
- Stance
- bullish
- On card
- no
Sentiment history
No sentiment history available for $PFE yet.
Sentiment
Notable posts
-
bullish 772 eng
π¨ CEO Buy Alert The CEO of Pfizer $PFE dropped $1,000,000 on his own stock last week while shares trade more than -55% below their 2021 peak. https://t.co/0z8AoLi6d0
view on X β -
neutral 590 eng
PREMARKET OPTIONS TRADING IS COMING Cboe plans to let traders buy and sell options on select major stocks before the regular market opens. Once live: 7:30β9:25 a.m. ET: Pre-market options trading 9:30 a.m.β4:00 p.m. ET: Regular session 4:00β4:15 p.m. ET: Extended βcurbβ session Initial stocks include $AAPL, $AMD, $AMZN, $AVGO, $BABA, $BAC, $GOOG, $GOOGL, $HOOD, $INTC, $META, $MSFT, $MU, $NFLX, $NOK, $NVDA, $ORCL, $PFE, $PLTR, $TSLA and $TSM. Orders can begin queuing at 7:15 a.m. ET. Launch date is still TBD.
view on X β -
bullish 50 eng
I almost never talk about dividend stocks. But there are actually a few getting interesting right now. Higher yield / more value: $UPS β ~7.0% yield | ~12x forward earnings $VZ β ~6.1% yield | ~9x forward earnings $PFE β ~6.0% yield | ~10x forward earnings $BMY β ~4.0% yield | ~10x forward earnings Lower yield / more growth: $NKE β ~4.5% yield | ~21x forward earnings $MCD β ~3.3% yield | ~18x forward earnings $LOW β ~2.7% yield | ~15x forward earnings $QCOM β ~2.0% yield | ~22x forward earnings I still wouldnβt buy any of these just for the dividend. Iβd rather own a business where the yield is just one part of the return. Which side are you taking?
view on X β -
neutral 34 eng
Pfizer $PFE said sigvotatug vedotin failed to significantly improve overall survival vs. docetaxel in advanced non-small cell lung cancer. Pfizer acquired the antibody-drug conjugate through its $43B Seagen deal. The company will continue developing the drug, including a late-stage combo study with Merckβs Keytruda in first-line lung cancer.
view on X β -
neutral 11 eng
WHITE HOUSE TO ANNOUNCE NEW DRUG PRICING DEALS WITH MIDSIZED BIOTECHS MONDAY The companies will discount outpatient drugs for state Medicaid programs so prices align with what they charge abroad, in exchange for exemptions from Medicare pilot programs, with tariff relief part of some discussions, per Bloomberg. Which drugmakers are participating is not yet known. The administration struck similar most-favored-nation deals with 17 large pharmaceutical companies starting last year, including Pfizer $PFE and Eli Lilly $LLY.
view on X β -
neutral 9 eng
Pfizer $PFE reaffirms FY2026 guidance following a CFO transition announcement, per an SEC filing.
view on X β -
neutral 25 eng
Tenet Market Wake-Up Summary π·π· June.18.26 $SPX $AAPL $INTC $AVGO $OKLO $LEU $META $TSLA $NOK $RUM $UUUU $QBTS $ONDS $ZETA $PFE $SPCX $TSEM $MRVL $SWBI $ACN $KR $ALB $ENPH $QURE $CEG $TLN $CURB $ENGN $INTU $CAST $LNKS $LPA $NVCR $LEGN @ripster47 | @tenet_research | @TenetCharts
view on X β -
neutral 25 eng
Tenet Market Wake-Up Summary π·π· June.08.26 $SPX $AAPL $NVDA $AMZN $BA $MA $V $UAL $AAL $DAL $JBLU $NOK $ABAT $UBER $NBIS $SPOT $CRWV $PFE $FCEL $CPB $ALOT $BIIB $CROX $CTSH $WRB $CBRS $ALL $CSR $GMHS $TNGX $MRVL $BW @ripster47 | @TENETTRADEGROUP | @TenetCharts https://t.co/zKMUGXnV7I
view on X β
Signal history
| Date | Score | Signal | Mentions | Rank |
|---|---|---|---|---|
| 2026-06-08 | 0.29 | Weak | 1 | β |
| 2026-06-18 | 0.51 | Developing | 2 | β |
| 2026-06-22 | 0.52 | Developing | 1 | β |
| 2026-08-15 | 0.61 | Developing | 1 | β |
| 2026-08-18 | 0.46 | Noisy | 1 | β |
| 2026-08-26 | 0.54 | Developing | 1 | β |
| 2026-08-27 | 0.55 | Developing | 1 | β |
| 2026-09-22 | 0.53 | Developing | 1 | β |
| 2026-09-25 | 0.59 | Developing | 1 | β |
| 2026-09-30 | 0.49 | Noisy | 1 | β |